Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017

BAYER AG (BAYN)

Real-time Quote. Real-time Tradegate - 08/25 11:50:04 am
95.976 EUR   -0.77%
08/23DJU.S. Lawmakers Plan Hearing Over Wave of Agriculture Mergers
08/22 BAYER : Not intended for U.S. and UK Media -- New Real-World Evidenc..
08/17 BAYER : and the Canadian Vascular Network (CVN) Announce the 2016 Re..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bayer AG : EARNINGS FORECAST TABLE : Bayer 4Q 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/22/2013 | 02:32pm CEST

FRANKFURT--The following is a summary of analysts' forecasts for Bayer AG (BAYN.XE) fourth-quarter results, based on a poll of 10 analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released February 28.

=== 
 
                          EBITDA   EBITDA   EBIT    EBIT 
4th Quarter        Sales    adj.    rep.    adj.  reported 
 
AVERAGE            9,726   1,811   1,585   1,092     901 
Prev. Year         9,191   1,541   1,415     844     629 
+/- in %            +5.8     +18     +12     +29     +43 
 
MEDIAN             9,743   1,821   1,585   1,102     841 
Maximum            9,905   1,893   1,633   1,191   1,053 
Minimum            9,536   1,707   1,536     970     808 
Amount (a)            10      10       2       6       5 
 
Baader Bank        9,725   1,839      --      --      -- 
Credit Suisse      9,793   1,831      --   1,191     966 
Deutsche Bank      9,559   1,869      --   1,135   1,053 
Equinet            9,760   1,820      --      --     838 
Exane BNP Paribas  9,611   1,817      --     970      -- 
J.P. Morgan        9,883   1,821   1,633   1,125      -- 
Nomura             9,536   1,707      --   1,078     808 
UBS                9,840   1,760      --      --      -- 
 
 
 
                  Net attrib.             EPS 
4th Quarter         income      EPS      core 
 
AVERAGE              468       0.55      1.06 
Prev. Year           397       0.48      0.97 
+/- in %             +18        +15      +9.3 
 
MEDIAN               494       0.53      1.06 
Maximum              549       0.66      1.12 
Minimum              332       0.46      1.00 
Amount (a)             8          6        10 
 
Baader Bank          542         --      1.02 
Credit Suisse        466       0.56      1.05 
Deutsche Bank        538         --      1.05 
Equinet               --       0.50      1.08 
Exane BNP Paribas    332         --      1.09 
J.P. Morgan          521       0.63      1.06 
Nomura               413       0.50      1.00 
UBS                   --         --      1.03 
 
 
 
               Target price  Rating                 DPS 2012 
 
AVERAGE               77.27  positive 6     AVERAGE     1.84 
Prev. Quarter         67.20  neutral  3     Prev. Year  1.65 
+/- in %                +15  negative 1     +/- in %     +11 
 
MEDIAN                75.00                 MEDIAN      1.83 
Maximum               90.00                 Maximum     1.94 
Minimum               65.60                 Minimum     1.77 
Amount                    9                 Amount         6 
 
Baader Bank           65.60  Hold                         -- 
Barclays              66.00  Underweight                1.81 
Citigroup             90.00  Buy                        1.85 
Commerzbank           90.00  Buy                          -- 
Credit Suisse         82.80  Outperform                 1.94 
Deutsche Bank         86.00  Buy                        1.77 
Equinet               75.00  Accumulate                 1.85 
Exane BNP Paribas     73.00  Neutral                    1.80 
J.P. Morgan              --  Overweight                   -- 
UBS                   67.00  Neutral                      -- 
=== 

Year-earlier figures are as reported by the company.

(a) Including anonymous estimates from two more institutes.

DJG/voi 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER AG
08/23DJU.S. Lawmakers Plan Hearing Over Wave of Agriculture Mergers
08/22 COVESTRO : Assigned Patent
08/22 BAYER : Not intended for U.S. and UK Media -- New Real-World Evidence on Venous ..
08/18 BAYER CROPSCIENCE : Research Conducted at Bayer CropScience Has Provided New Inf..
08/17 BAYER : and the Canadian Vascular Network (CVN) Announce the 2016 Research Fello..
08/15 Covestro LLC Receives US2020's 2016 STEM Mentoring Award for 'Excellence in C..
08/12 COVESTRO : Longer lives, greater financial needs lead to delayed retirements
08/11DJEU Opens Antitrust Probe on Dow Chemical-DuPont Merger
08/11 Covestro LLC Receives US2020's 2016 STEM Mentoring Award for 'Excellence in C..
08/05 BAYER : reported to be reviewing Monsanto's books as it mulls higher bid
More news
Sector news : Pharmaceuticals - NEC
11:37aDJShares Fall as Health-Care Sector Loses Ground -- Update
10:35aDJShares Fall as Health-Care Sector Loses Ground
08:49aDJPFIZER : to Buy Some Of Astra's Antibiotics -- WSJ
08/24DJPFIZER : Buys Part of AstraZeneca's Antibiotics Business -- 2nd Update
08/24DJASTRAZENECA : Sells Part of its Antibiotics Business to Pfizer -- Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/23 Who's Next After Medivation?
08/23 Apple Wants You To Feel Better
08/23 BLOOMBERG : Bayer, Monsanto moving closer to deal
08/22 Berkshire Boosts Apple Stake And Other Moves From Top Managers
08/19 Bayer/CRISPR Therapeutics joint venture Casebia Therapeutics establishes oper..